Monoclonal Antibodies

The second line will focus on the production of biosimilar monoclonal antibodies, used in the treatment of serious diseases such as cancers (breast, colon, lung), chronic inflammatory diseases (rheumatoid arthritis, Crohn’s disease), and certain autoimmune conditions. This line will provide access to innovative, high-quality treatments manufactured locally